Please check your internet connection and try again.
# Urimax (Tamsulosin)
## Overview
Tamsulosin is a selective α1-adrenoceptor antagonist that preferentially blocks α1A receptors found in the prostate and bladder neck, causing smooth muscle relaxation and improving urinary flow.
## Primary Indications
* Treatment of signs and symptoms of Benign Prostatic Hyperplasia (BPH).
* Off-label: Medical expulsive therapy for ureteral calculi.
## Adult Dosing
* **BPH:** 0.4 mg orally once daily, taken 30 minutes after the same meal each day.
* **Maximum Dose:** 0.8 mg daily. If no improvement is seen with 0.4 mg after 2–4 weeks, the dose may be increased to 0.8 mg.
## Pediatric Dosing
* **Status:** Not FDA-approved for pediatric use.
* **Off-label/Specialist Use:** Used in specific pediatric populations (e.g., voiding dysfunction/neurogenic bladder) under specialized nephrology/urology guidance. Dosing is highly variable and depends on institutional protocols; do not initiate without specialist oversight.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment required for mild to moderate impairment. Use caution in severe impairment.
* **Hepatic Impairment:** No specific adjustment in mild to moderate impairment. Avoid use in severe hepatic impairment.
* **CYP3A4/2D6 Inhibitors:** Reduce dose or avoid concurrent administration with potent inhibitors.
## Contraindications
* Known hypersensitivity (e.g., angioedema, urticaria) to tamsulosin.
* History of orthostatic hypotension.
## Adverse Effects
* **Common:** Dizziness, headache, infection, asthenia, rhinitis.
* **Serious:** Orthostatic hypotension (syncope/presyncope), Intraoperative Floppy Iris Syndrome (IFIS) during cataract surgery, priapism (rare).
## Key Drug Interactions
* **PDE-5 Inhibitors (e.g., Sildenafil, Tadalafil):** Use caution; additive blood pressure lowering effects may lead to symptomatic hypotension.
* **Strong CYP3A4 Inhibitors (e.g., Ketoconazole, Ritonavir):** Significantly increase tamsulosin exposure.
* **Strong CYP2D6 Inhibitors (e.g., Paroxetine, Fluoxetine):** May increase exposure.
## Monitoring
* Monitor blood pressure periodically (especially during initiation or dose escalation).
* Monitor for symptomatic orthostasis.
* Evaluate patient for prostate cancer prior to treatment initiation as symptoms may overlap.
* If patient requires cataract or glaucoma surgery, inform the ophthalmologist of current or prior tamsulosin use.
## Clinical Pearls
* **Administration:** Must be taken 30 minutes after the same meal consistently to reduce the risk of orthostatic hypotension by stabilizing systemic absorption.
* **Surgical Risk:** Advise patients to disclose tamsulosin history to their surgeon prior to cataract surgery due to the risk of IFIS.
* **Onset:** Symptomatic relief in BPH usually occurs within 1–2 weeks, but can take up to 4 weeks.
***
**Educational Disclaimer:** This information is intended for educational purposes for healthcare professionals. Dosage and clinical practices may vary based on local guidelines, patient comorbidities, and institutional protocols. Always consult the latest package insert and clinical resources (e.g., Lexicomp, UpToDate) before prescribing or administering medication.
